Markets
AAT

Sector Update: Healthcare Shares Mixed Pre-Market; Abbot Lower on Plans to Buy CFR Pharmaceuticals

Top Healthcare stocks:

JNJ: flat

PFE: -0.21%

ABT: +1.40%

MRK: -0.09%

AMGN: -0.06%

Healthcare shares were generally lower in pre-market trade on Friday.

In healthcare stocks news, Kamada ( KMDA ) is lower after the company announced preliminary top-line results from the Phase II/III pivotal clinical trial in Europe and Canada of its proprietary inhaled Alpha-1 Antitrypsin ( AAT ) therapy to treat Alpha-1 Antitrypsin Deficiency (AATD or inherited emphysema).

And, Abbott ( ABT ) edged lower in recent pre-market trading on Friday after saying it has signed a definitive agreement to buy Latin American pharmaceutical company CFR Pharmaceuticals for approximately $2.9 billion, plus the assumption of debt of approximately $430 million.

ABT closed down to $39.24 Thursday, in a 52-week range of $32.70 - $40.49.

And, Bovie Medical ( BVX ) said late Thursday Q1 sales were $6.5 million, up 14% from a year ago. Adjusted net loss was $0.01 per share, down from a loss of $0.02 last year.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

AAT KMDA ABT

Other Topics

Commodities

Latest Markets Videos

    MTNewswires

    Founded in 1999, MT Newswires (formerly known as Midnight Trader) is a leading provider of original source, multi-asset class, real-time, global financial news and information to most of the largest banks, brokerage firms and professional market data, trading & research applications in North America.

    Learn More